Evidence map›Paper›PMID 24481132›Full record

ArticleNutrients2014

Effect of fructooligosaccharides fraction from Psacalium decompositum on inflammation and dyslipidemia in rats with fructose-induced obesity.

Héctor Merino-Aguilar, Daniel Arrieta-Baez, Manuel Jiménez-Estrada, Gil Magos-Guerrero, René Javier Hernández-Bautista, Ana Del Carmen Susunaga-Notario, Julio Cesar Almanza-Pérez, Gerardo Blancas-Flores, Rubén Román-Ramos, Francisco Javier Alarcón-Aguilar

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Effect of a fructooligosaccharides fraction fromBioscience of microbiota, food and health · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Antihypertensive, antidyslipidemic, and renoprotective effects ofIranian journal of basic medical sciences · 2023
    Article
  11. Review
  12. Review
  13. Review
  14. Chemoinformatic Analysis of Selected Cacalolides fromMolecules (Basel, Switzerland) · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Immuno-modulator metallo-Peptide reduces inflammatory state in obese zucker fa/fa rats.International journal of biomedical science : IJBS · 2014
    Article
  20. Effect ofIranian journal of pharmaceutical research : IJPR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Héctor Merino-AguilarPrograma de Doctorado en Ciencias Biológicas y de la Salud. D.C.B.S., Universidad Autónoma Metropolitana-Iztapalapa, Apdo-Postal 55-535, México D.F. C.P. 09340, Mexico. hmerino@ciencias.unam.mx.
Daniel Arrieta-BaezInstituto Politécnico Nacional-CNMN, Calle Luis Enrique Erro s/n, Unidad Profesional Adolfo López Mateos, Col. Zacatenco, México D.F. C.P. 07738, Mexico. danielarrieta@hotmail.com.
Manuel Jiménez-EstradaInstituto de Química, Universidad Nacional Autónoma de México, Coyoacán, México D.F. C.P. 04510, Mexico. manueljemex@gmail.com.
Gil Magos-GuerreroFacultad de Medicina, Universidad Nacional Autónoma de México, Coyoacán, México D.F. C.P. 04510, Mexico. gamagos@unam.mx.
René Javier Hernández-BautistaPrograma de Doctorado en Biología Experimental, D.C.B.S., Universidad Autónoma Metropolitana-Iztapalapa, Apdo-Postal 55-535, México D.F. C.P. 09340, Mexico. rjhb11@yahoo.com.mx.
Ana Del Carmen Susunaga-NotarioPrograma de Doctorado en Biología Experimental, D.C.B.S., Universidad Autónoma Metropolitana-Iztapalapa, Apdo-Postal 55-535, México D.F. C.P. 09340, Mexico. qfbsus@yahoo.com.mx.
Julio Cesar Almanza-PérezDepartamento de Ciencias de la Salud, D.C.B.S., Universidad Autónoma Metropolitana-Iztapalapa, Apdo-Postal 55-535, México D.F. C.P. 09340, Mexico. jcap@xanum.uam.mx.
Gerardo Blancas-FloresDepartamento de Ciencias de la Salud, D.C.B.S., Universidad Autónoma Metropolitana-Iztapalapa, Apdo-Postal 55-535, México D.F. C.P. 09340, Mexico. gera@xanum.uam.mx.
Rubén Román-RamosDepartamento de Ciencias de la Salud, D.C.B.S., Universidad Autónoma Metropolitana-Iztapalapa, Apdo-Postal 55-535, México D.F. C.P. 09340, Mexico. rrr@xanum.uam.mx.
Francisco Javier Alarcón-AguilarDepartamento de Ciencias de la Salud, D.C.B.S., Universidad Autónoma Metropolitana-Iztapalapa, Apdo-Postal 55-535, México D.F. C.P. 09340, Mexico. aaasj2@prodigy.net.mx.
Universidad Autónoma Metropolitana · MXUniversidad Nacional Autónoma de México · MXInstituto Politécnico Nacional · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psacalium decompositum, commonly known as "Matarique," is a medicinal plant used in Mexico for diabetes mellitus empirical therapy. Previous studies have shown that the fructooligosaccharides (FOS) present in the roots of this plant exhibit a notable hypoglycemic effect in animal models; this effect might be associated with the attenuation of the inflammatory process and other metabolic disorders. In this study, we examined the effects of FOS fraction administration in a fructose-fed rat model for obesity. Phytochemical chromatographic studies (high performance thin layer chromatography and nuclear magnetic resonance) were performed to verify isolation of FOS. 24 male Wistar rats were maintained for 12 weeks on a diet of 20% HFCS in drinking water and chow. Glucose, cholesterol, triglycerides and liver transaminases levels were measured monthly, after administering FOS fraction intragastrically (150 mg/kg/day for 12 weeks), while the levels of inflammatory cytokines were only quantified at the end of the treatments. Rats treated with FOS fraction decreased body weight, cholesterol, triglycerides, and significantly reduced IL-6, IFN-γ, MCP-1, IL-1β and VEGF levels (p < 0.05). These results suggest that P. decompositum has anti-inflammatory and hypolipidemic properties that might be used as an alternative treatment for the control of obesity.

Indexed as

AnimalsAnti-Inflammatory AgentsAsteraceaeBody WeightChemokine CCL2CholesterolDisease Models, AnimalDyslipidemiasFructoseHypoglycemic AgentsInflammationInterferon-gammaInterleukin-1betaInterleukin-6MaleObesityAnti-Inflammatory AgentsCcl2 protein, ratChemokine CCL2CholesterolfructooligosaccharideFructoseHypoglycemic AgentsInterferon-gammaInterleukin-1betaInterleukin-6OligosaccharidesPlant ExtractsTriglyceridesVascular Endothelial Growth Factor Avascular endothelial growth factor A, rat

Identifiers

PMID24481132
PMCPMC3942719
OpenAlexW2016453980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.